PsychU

Sorry, this content is no longer available.

Explore Other Content
Welcome to PsychU!
Improving mental health care...together

Treatment Pathways Across Cultures

On-Demand Webinar November 25, 2024
  1. Home
  2. Patient & Caregiver Resource Center
  3. Treatment Pathways Across Cultures
Download Slidedeck

Understanding the cultural aspects of treating bipolar disease offers invaluable insights into how diverse ethnic backgrounds influence the perception, diagnosis and the management of this condition. Appreciating these differences can improve communication between healthcare providers and patients and lead to more improved, personalized and effective healthcare treatment plans. During this webinar, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact of culture across treatment pathways for bipolar disorder, and how cultural context can be integrated into treatment strategies for this condition.

Featuring

Michael-Aldape

Michael Aldape, PhD (OPDC)

Senior Medical Science Liaison

Crystal T.-Clark

Crystal T. Clark, MD, MSc

Associate Professor, Department of Psychiatry, University of Toronto; Research Investigator, Associate Head of Research, Department of Psychiatry, Women’s College Hospital (Toronto, Ontario)

More
Dr. Clark is an Associate Professor in the Department of Psychiatry at the University of Toronto. She is also a scientist at Women’s College Research Institute and will serve as the Associate Head of Research at the Women’s College Hospital. Dr. Clark is a past president of the Marcé of North America and serves on the board of directors of Marcé International. She received her Bachelor of Arts in Psychology from Northwestern University and her Master of Science and Medical Doctorate from the University of Louisville, Kentucky (2006). She completed her adult psychiatry training and served as chief resident at Johns Hopkins in Baltimore, Maryland, USA (2010). Prior to completing her MSc in Clinical Investigation Sciences (2012), she completed fellowship training in clinical research and reproductive psychiatry while also serving on faculty at the Baylor College of Medicine/Michael E. Debakey VA as well as the University of Pittsburgh Medical Center/ Pittsburgh VA Healthcare Systems. Prior to joining UofT, she served as an Associate Professor at Northwestern University, Chicago. There she was a Staff Psychiatrist at the Northwestern Memorial Hospital; and Clinical Director of the Women’s Outpatient Program, Asher Center for the Study and Treatment of Depressive Disorders. She also co-founded and co-directed and advanced training fellowship in women’s and reproductive mental health.
Mauricio-Tohen

Mauricio Tohen, MD, DrPH, MBA

Chairman, Department of Psychiatry and Behavioral Sciences, Distinguished University Professor, University of New Mexico

More
Dr. Tohen is a Distinguished University Professor at the University of New Mexico and the Chairman of the University of New Mexico’s Department of Psychiatry and Behavioral Sciences. With more than 350 publications and 20,000 scientific citations to his name, Dr. Tohen received in 2016 the Mogens Schou Award for Education and Teaching from the International Society for Bipolar Disorders. In 2017, Dr. Tohen was recognized as one of the world’s leading experts on bipolar disorder based on the breadth and depth of his publications. He earned his medical degree from the National University of Mexico and his Doctorate in Public Health (Epidemiology) from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto, where he additionally obtained a DPsych (Diploma) in Psychiatric Research, and a fellowship at McLean Hospital, Harvard Medical School in Psychopharmacology. Dr. Tohen also obtained an MBA degree from the Indiana University Kelly School of Business. 

Dr. Michael Aldape, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Dr. Mauricio Tohen, MD, DrPH, MBA and Dr. Crystal Clark, MD, MSc are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.

September 2024 US.CORP.X.24.00280 / US.CORP.D.24.00036

Upcoming Events

View All Upcoming Events

On-Demand Webinars

View On-Demand Webinar Library

Stay Connected: